The Debate Over Research and Publicity

The narrative shows how publicity can open access and generate cultural change while also undermining scientific legitimacy and provoking suppression.

increasingBearing stren­gth in each eventdecreasing

Research Circulates Freely

An Unusual Supply System Sandoz invites exploration The company supplies LSD to investigators, encouraging a broad and collaborative research effort. Scientific and clinical questions multiply faster than any single framework can answer them. Opportunity carries risk Researchers’ own experiences can sharpen their insight but also intensify enthusiasm. The line between observation and advocacy begins to blur.

Celebrity Therapy Goes Public

A Treatment Becomes a Fad Endorsements attract attention Positive publicity around LSD therapy, including celebrity testimony, increases public interest and demand. Treatment begins to escape the narrow world of research. A warning sign Commercial and social uses are harder to distinguish from clinical work. The question of who should administer the drug becomes urgent.

Leary’s Public Campaign

Publicity as Strategy A message aimed at society Leary openly advocates widespread psychedelic use and ties it to personal and cultural transformation. His slogans reach audiences that academic papers never could. A backlash takes shape The same visibility alarms officials and families. Advocacy amplifies the movement while making careful research appear inseparable from public revolt.

The Press and the Panic

Danger Becomes the Dominant Story Dramatic incidents circulate Headlines and urban legends magnify the threat of LSD. Some real adverse events are mixed with false or exaggerated claims. Nuance disappears Balanced assessments receive less attention than alarming narratives. The press climate makes it politically difficult to preserve distinctions between supervised therapy and illicit use.

The Research Shutdown

A Decade of Work Ends Supply and permission withdrawn Sandoz withdraws LSD, and federal authorities order research programs to stop. A broad field loses access to its central tools. A divided inheritance The shutdown reflects publicity, political reaction, methodological problems, and the drugs’ disruptive reputation. No single person explains the collapse, though Leary becomes its symbol.

From 1949 through the early 1960s

Around 1959

From 1962 through 1967

During the mid-1960s

In 1966